Skip to main content
Watch Insiders
CATXHealthcare

Perspective Therapeutics Inc (CATX) Insider Trading

In the last 90 days, 2 Perspective Therapeutics Inc (CATX) insiders reported no open-market purchases and 7 sales totaling $2,530,700. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 4, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 4, 2026Lantheus Holdings Inc.Corporate insiderSale247,932$3.13$776,945
Sep 4, 2026Lantheus Alpha Therapy LLCCorporate insiderSale247,932$3.13$776,945
Sep 2, 2026Lantheus Holdings Inc.Corporate insiderSale42,129$3.11$131,219
Sep 2, 2026Lantheus Alpha Therapy LLCCorporate insiderSale42,129$3.11$131,219
Sep 1, 2026Lantheus Alpha Therapy LLCCorporate insiderSale113,914$3.14$357,189
Sep 1, 2026Lantheus Holdings Inc.Corporate insiderSale35,769$3.12$111,574
Aug 31, 2026Lantheus Holdings Inc.Corporate insiderSale78,145$3.14$245,610

Common questions

CATX insider trading FAQ

Are CATX insiders buying or selling?
Over the last 90 days, CATX insiders were net sellers, reporting $0.00 of open-market purchases and $2,530,700 of sales.
When was the last CATX insider purchase?
No open-market insider purchase of Perspective Therapeutics Inc stock was reported in the last 90 days.
Where does CATX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Perspective Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.